XML 75 R59.htm IDEA: XBRL DOCUMENT v3.23.1
STOCKHOLDERS’ EQUITY (Stock Options Activity) (Details)
$ / shares in Units, shares in Thousands, $ in Thousands
 3 Months Ended
Mar. 31, 2023
USD ($)
$ / shares
shares
Number of Options   
Beginning balance (in shares) | shares 1,923
Options granted (in shares) | shares 108
Options exercised (in shares) | shares (72)
Ending balance (in shares) | shares 1,959
Options vested and exercisable at period end (in shares) | shares 1,665
Options expected to vest at period end (in shares) | shares 272
Weighted Average Exercise Price   
Options outstanding at beginning of period (in usd per share) | $ / shares $ 98.92
Options granted (in usd per share) | $ / shares 299.00
Options exercised (in usd per share) | $ / shares 35.54
Options outstanding at end of period (in usd per share) | $ / shares 112.21
Options vested and exercisable at period end (in usd per share) | $ / shares 79.73
Options expected to vest at period end (in usd per share) | $ / shares $ 295.97
Aggregate Intrinsic Value   
Options outstanding at March 31, 2023 | $ $ 376,403
Options vested and exercisable as of March 31, 2023 | $ 369,504
Options expected to vest as of March 31, 2023 | $ $ 6,519
Weighted Average Remaining Contractual Term (in years)  
Options outstanding at March 31, 2023 3 years 7 months 6 days
Options vested and exercisable as of March 31, 2023 2 years 8 months 12 days
Options expected to vest as of March 31, 2023 9 years